|
|
|
2012 Global HIV/AIDS Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country
4/20/2012 | published by: Venture Planning Group
The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and
|
more...
|
$4,850.00
|
|
2012 Global Syphilis Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country
4/20/2012 | published by: Venture Planning Group
The report presents a detailed analysis of the Syphilis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Syphilis definition, epidemiology and etiology are reviewed.
|
more...
|
$3,850.00
|
|
Syphilis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
2/29/2012 | published by: GlobalData
Syphilis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Syphilis Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source
|
more...
|
$3,995.00
|
|
Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019
3/31/2012 | published by: GlobalData
Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source
|
more...
|
$3,995.00
|
|
The 2012 Herpes Diagnostics Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country
3/28/2012 | published by: Venture Planning Group
The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed.
|
more...
|
$4,850.00
|
|
Gonorrhea Global Clinical Trials Review, H1, 2012
2/29/2012 | published by: GlobalData
Gonorrhea Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Gonorrhea Global Clinical Trials Review, H1, 2012 provides data on the Gonorrhea clinical trial scenario. This report provides elemental information and data relating to the
|
more...
|
$1,000.00
|
|
The 2012 HIV/AIDS Diagnostics Market: US, Europe, Japan--Sales Forecasts and Supplier Shares by Country
3/28/2012 | published by: Venture Planning Group
The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and
|
more...
|
$4,850.00
|
|
Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies
4/1/2012 | published by: GBI Research
Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies Summary GBI Research's report Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies finds
|
more...
|
$3,500.00
|
|
HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019
2/29/2012 | published by: GlobalData
HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an
|
more...
|
$3,995.00
|
|
Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
2/29/2012 | published by: GlobalData
Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an
|
more...
|
$3,995.00
|
Related Markets
AIDS, HIV & STDs Reports
- Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market
- Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies
- Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019
- Syphilis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
- Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
